Oromandibular Dystonia Related to Sertraline Treatment in a Child

dc.contributor.authorKutuk, Meryem Ozlem
dc.contributor.authorAksu, Gulen Guler
dc.contributor.authorTufan, Ali Evren
dc.contributor.authorCelik, Tamer
dc.contributor.orcIDhttps://orcid.org/0000-0002-2918-7871en_US
dc.contributor.pubmedID30575411en_US
dc.contributor.researcherIDAAI-9626-2021en_US
dc.date.accessioned2023-09-06T08:39:44Z
dc.date.available2023-09-06T08:39:44Z
dc.date.issued2019
dc.description.abstractIn children, similar to adults, the agents that cause movement disorders are most commonly dopaminergic and antidopaminergic drugs. However, it is also known that selective serotonin reuptake inhibitors (SSRIs), which are frequently prescribed in child psychiatry practice, may rarely lead to tremor, akathisia, dystonia, dyskinesia, and parkinsonism. In this study, we report a rare side effect of SSRIs, namely oromandibular dystonia related to sertraline, in a pediatric patient who was diagnosed with posttraumatic stress disorder.en_US
dc.identifier.endpage165en_US
dc.identifier.issn1044-5463en_US
dc.identifier.issue2en_US
dc.identifier.scopus2-s2.0-85062622604en_US
dc.identifier.startpage164en_US
dc.identifier.urihttp://hdl.handle.net/11727/10497
dc.identifier.volume29en_US
dc.identifier.wos000465299300012en_US
dc.language.isoengen_US
dc.relation.isversionof10.1089/cap.2018.0118en_US
dc.relation.journalJOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectpsychopharmacologyen_US
dc.subjectdystoniaen_US
dc.subjectsertralineen_US
dc.subjectchildrenen_US
dc.titleOromandibular Dystonia Related to Sertraline Treatment in a Childen_US
dc.typeletteren_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: